The combination of different types of antitumor topoisomerase II inhibitors, ICRF-193 and VP-16, has synergistic and antagonistic effects on cell survival, depending on treatment schedule (Q71776593)
scientific article published on 01 September 1996
Language:
Current Data About The combination of different types of antitumor topoisomerase II inhibitors, ICRF-193 and VP-16, has synergistic and antagonistic effects on cell survival, depending on treatment schedule
(P31) (Q13442814)
(P248)
(P698) 8917380
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8917380%20AND%20SRC:MED&resulttype=core&format=json
(P813) Monday, October 21, 2019

(P304) 2735-2740
(P248)
(P698) 8917380
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8917380%20AND%20SRC:MED&resulttype=core&format=json
(P813) Monday, October 21, 2019

(P407) (Q1860)

(P433) 5A
(P248)
(P698) 8917380
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8917380%20AND%20SRC:MED&resulttype=core&format=json
(P813) Monday, October 21, 2019

(P478) 16
(P248)
(P698) 8917380
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8917380%20AND%20SRC:MED&resulttype=core&format=json
(P813) Monday, October 21, 2019

(P577) Sunday, September 1, 1996
(P248)
(P698) 8917380
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8917380%20AND%20SRC:MED&resulttype=core&format=json
(P813) Monday, October 21, 2019

(P921) (Q418817)
(P887)

(P1433) (Q326290)
(P248)
(P698) 8917380
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8917380%20AND%20SRC:MED&resulttype=core&format=json
(P813) Monday, October 21, 2019

(P1476) "The combination of different types of antitumor topoisomerase II inhibitors, ICRF-193 and VP-16, has synergistic and antagonistic effects on cell survival, depending on treatment schedule" (language: en)
(P248)
(P698) 8917380
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8917380%20AND%20SRC:MED&resulttype=core&format=json
(P813) Monday, October 21, 2019

(P2093) Ishida R
(P1545) 1
(P248)
(P698) 8917380
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8917380%20AND%20SRC:MED&resulttype=core&format=json
(P813) Monday, October 21, 2019

Iwai M
(P1545) 2
(P248)
(P698) 8917380
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8917380%20AND%20SRC:MED&resulttype=core&format=json
(P813) Monday, October 21, 2019

Hara A
(P1545) 3
(P248)
(P698) 8917380
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8917380%20AND%20SRC:MED&resulttype=core&format=json
(P813) Monday, October 21, 2019

Andoh T
(P1545) 4
(P248)
(P698) 8917380
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8917380%20AND%20SRC:MED&resulttype=core&format=json
(P813) Monday, October 21, 2019

other details
description scientific article published on 01 September 1996

External Links
(P698) 8917380